• news

The 2020 Blue Faery Award for Excellence in Liver Cancer Research is open for nominations. We have switched from an email submission process to an electronic form. For more…

Blue Faery has partnered with Cancer Support Community (CSC) to encourage liver cancer patients and caregivers  to join the Cancer Experience Registry.

The Cancer Experience Registry: Liver Cancer is a…

Article for Blue Faery by Kenichi Nomoto
Interviewed by Cindy Gessell, Senior Consultant, Eisai Inc.

Thirty-five years later, driven by personal and professional passion, Dr. Kenichi Nomoto expands the liver cancer…

Seeking HCC Patients Currently Taking Lenvima

If you reside in the US, have been diagnosed with Stage III or IV unresectable Hepatocellular Carcinoma (primary liver cancer), and you are currently…

Blue Faery's Liver Cancer News page has been updated to reflect the most current news and medical updates about primary liver cancer aka Hepatocellular Carcinoma (HCC). If you…

By Mark Feitelson, Ph.D., Department of Biology, Temple University, Philadelphia, PA 19122

Millions of people worldwide suffer from chronic liver disease (CLD) associated with hepatitis B and C virus…

As a patient advocate representative, President Andrea Wilson attended the first Hepatobiliary SPORE Meeting at the Mayo Clinic in Rochester. Several other liver cancer advocates were present including executives…

Attention Donors: we no longer use Network For Good as our payment processor. After much evaluation and cost analysis, we have decided to process all future online donations through…

President Andrea Wilson, Blue Faery Booth Manager Elizabeth Marquez and Volunteer Edward Hinton attended ASCO’s annual meeting in Chicago from May 31 – June 4. For the fourth year…

Dr. Jinsil Seong Wins 2019 Blue Faery Award for Excellence in Liver Cancer Research

Professor Seong is one of a few who pioneered radiotherapy of Hepatocellular…